Skip to content

Public FDA record

Z-2657-2017: CardioTek EP-TRACER Software V1.x and V2.0 The EP-TRACER System is an electrophysiology measurement syst

Recall record Z-2657-2017 for CardioTek BV. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2657-2017
Company in FDA record
CardioTek BV
FDA record creation date
Jun 30, 2017
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Software bug which allows parameters to be changed unintentionally during use.

Source facts

Action
The Firm, Schwarzer cardiotek, sent an "Urgent Field Safety Notice" dated 4/21/2017 to its consignees. The notice described the product, problem and actions to be taken. The consignees were instructed to do the following: " While backup pacing is active the software must not be operated. " In case of backup pacing disconnect all catheter connection pins and reconnect only the two required for stimulation to the dedicated backup pacing output ports (OUT1 or OUT2). " If the backup pacing parameters were changed by accident quickly switch backup pacing off and on again to reset the parameters. " Ensure that the system is only operated by trained users. The firm plans to do the following: " provide an amendment to the hardware manual concerning the correct use of the backup pacing functionality to all service partners and customers. An updated software, which prevents accidental change of backup pacing parameters will be made available. Upon receipt of the amendment and installation of the software update, the completed feedback form must be returned to CardioTek no later than 3/4/2018 by fax +49 7131 2774 590 or email: Service@schwarzercardiotek.com. If you have any questions, please contact Sales & Service at +49 172 790 9112 or email: Service@schwarzercardiotek.com.
Initiated
2017-04-13
Root cause
Software design
Distribution
Worldwide Distribution: US (nationwide) to states of: CA, IL, OH, and MN; and countries of: Albania, Algeria, Argentina, Bangladesh, Belgium, Bolivia, Brazil, Canada, Chile, Colombia, Costa Rica, Croatia, Cuba, Czech Rep, Denmark, Ecuador, Egypt, Estonia, Finland, France, Georgia, Germany, Greece, Guatemala, Honduras, Hungary, India, Indonesia, Iran, Iraq, Ireland, Israel, Italy, Jamaica, Jordan, Kosovo, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malaysia, Malta, Mexico, Monaco, Morocco, Netherlands, Norway, Pakistan, Palestine, Peru, Philippines, Poland, Portugal, Rep. Dominicana, Romania, Russia, Saudi Arabia, Singapore, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Syria, Trinidad & Tobago, Turkey, United Arab Emirates, United Kingdom, Venezuela and Vietnam.
Recall number
Z-2657-2017
Recall status
Completed
CDRH record ID
154842
FDA record created
2017-06-30
Recall event number
77025

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗